$47.91 -0.58 (-1.20%)
2/10/2012 4:02 PM

Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Featured Broker Partners


Advertisement